The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
Open accessAbstract
Summary Multiple Myeloma (MM) remains incurable despite novel therapies, suggesting the need for further identification of factors mediating tumorigenesis and drug resistance. Using both in vitro and in vivo MM xenograft models, we show that plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) microenvironment both mediate immune deficiency characteristic of MM and promote MM cell growth, survival, and drug resistance. Microarray, cell signaling, cytokine profile and immunohistochemical analysis delineate the mechanisms mediating these sequelae. Although pDCs are resistant to novel therapies, targeting Toll-like Receptors with CpG ODNs both restores pDC immune function and abrogates pDC-induced MM cell growth. Our study therefore validates targeting pDC-MM interactions as a therapeutic strategy to overcome drug resistance in MM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,424
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Improved survival in multiple myeloma and the impact of novel therapies
Kumar, S. K., Rajkumar, S. V., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Zeldenrust, S. R., Dingli, D., Russell, S. J., Lust, J. A., et al. (2008) · Blood · doi:10.1182/blood-2007-10-116129 · Cited by 2,240
Self-citationImmunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190
Grouard, G., Rissoan, M.-C., Filgueira, L., Durand, I., Banchereau, J., & Liu, Y.-J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1101 · Cited by 1,189
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067 · cited 2×
“Importantly, pDCs play a role in normal B cell development into plasmablasts, their differentiation into antibody-secreting plasma cells, and their survival (Garcia De Vinuesa et al., 1999; Jego et al., 2003; Poeck et al., 2004; Tabera et al., 2008).”
BackgroundIDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., Lustig, D. S., & Cohn, Z. A. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.6.1431 · Cited by 1,050
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Self-citationBarrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1823 · Cited by 766
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694 · cited 10×
“DNA synthesis was measured by (3H)thymidine uptake (3H-Tdr) (PerkinElmer, Boston, MA), as previously described (Chauhan et al., 2005).”
BackgroundMethodInfluentialSelf-citationZou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 653
Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells
Gilliet, M., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011603 · Cited by 638
Moseman, E. A., Liang, X., Dawson, A. J., Panoskaltsis-Mortari, A., Krieg, A. M., Liu, Y.-J., Blazar, B. R., & Chen, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4433 · Cited by 637
O’Doherty, U., Peng, M., Gezelter, S., Swiggard, W. J., Betjes, M. G. H., Bhardwaj, N., & Steinman, R. M. (1994) · PubMed Central · Cited by 601
Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.3.1104.bloodjournal8731104 · Cited by 563
Self-citationMolecular Pathogenesis and a Consequent Classification of Multiple Myeloma
Bergsagel, P. L., & Kuehl, W. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.021 · Cited by 556
Recent major improvement in long-term survival of younger patients with multiple myeloma
Brenner, H., Gondos, A., & Pulte, D. (2008) · Blood · doi:10.1182/blood-2007-08-104984 · Cited by 535
Oerlemans, R., Franke, N. E., Assaraf, Y. G., Cloos, J., van Zantwijk, I., Berkers, C. R., Scheffer, G. L., Debipersad, K., Vojtekova, K., Lemos, C., et al. (2008) · Blood · doi:10.1182/blood-2007-08-104950 · Cited by 454
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Della Cuna, G. R., Tura, S., et al. (2002) · Blood · doi:10.1182/blood.v100.1.230 · Cited by 442
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
McKenna, K., Beignon, A.-S., & Bhardwaj, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.17-27.2005 · Cited by 394
Brown, R. D., Pope, B., Murray, A., Esdale, W., Sze, D. M., Gibson, J., Ho, P. J., Hart, D., & Joshua, D. (2001) · Blood · doi:10.1182/blood.v98.10.2992 · Cited by 347
Liu, C., Lou, Y., Lizée, G., Qin, H., Liu, S., Rabinovich, B., Kim, G. J., Wang, Y.-H., Ye, Y., Sikora, A. G., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33583 · Cited by 316
Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., & Dhodapkar, K. M. (2006) · Blood · doi:10.1182/blood-2006-03-011353 · Cited by 311
Poeck, H., Wagner, M., Battiany, J., Rothenfusser, S., Wellisch, D., Hornung, V., Jahrsdorfer, B., Giese, T., Endres, S., & Hartmann, G. (2004) · Blood · doi:10.1182/blood-2003-08-2972 · Cited by 303
Tabera, S., Perez-Simon, J. A., Diez-Campelo, M., Sanchez-Abarca, L. I., Blanco, B., Lopez, A., Benito, A., Ocio, E., Sanchez-Guijo, F. M., Canizo, C., et al. (2008) · Haematologica · doi:10.3324/haematol.12857 · Cited by 283
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells
Lee, J. W., Chung, H. Y., Ehrlich, L. A., Jelinek, D. F., Callander, N. S., Roodman, G. D., & Choi, S. J. (2004) · Blood · doi:10.1182/blood-2003-06-1992 · Cited by 239
Dysfunctional T regulatory cells in multiple myeloma
Prabhala, R. H., Neri, P., Bae, J. E., Tassone, P., Shammas, M. A., Allam, C. K., Daley, J. F., Chauhan, D., Blanchard, E., Thatte, H. S., et al. (2006) · Blood · doi:10.1182/blood-2005-08-3101 · Cited by 239
Self-citationManches, O., Munn, D., Fallahi, A., Lifson, J., Chaperot, L., Plumas, J., & Bhardwaj, N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34823 · Cited by 228
Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions
Dzionek, A., Inagaki, Y., Okawa, K., Nagafune, J., Röck, J. Ü., Sohma, Y., Winkels, G., Zysk, M., Yamaguchi, Y., & Schmitz, J. Ü. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00752-8 · Cited by 221
Dendritic Cells, BAFF, and APRIL
MacLennan, I. C. M., & Vinuesa, C. G. (2002) · Immunity · doi:10.1016/s1074-7613(02)00398-9 · Cited by 194
Ribatti, D., Nico, B., & Vacca, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209456 · Cited by 174
Dendritic cells associated with plasmablast survival
Vinuesa, C. G., Gulbranson‐Judge, A., Khan, M., O’Leary, P., Cascalho, M., Wabl, M. R., Klaus, G. G. B., Owen, M. J., & MacLennan, I. C. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3712::aid-immu3712>3.0.co;2-p · Cited by 153
RANK ligand as a therapeutic target for bone metastases and multiple myeloma
Roodman, G. D., & Dougall, W. C. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.09.002 · Cited by 142
Singh, A., Franke, A. A., Blackburn, G. L., & Zhou, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1332 · Cited by 135
Self-citationEnhancement of clonogenicity of human multiple myeloma by dendritic cells
Kukreja, A., Hutchinson, A., Dhodapkar, K. M., Mazumder, A., Vesole, D. H., Angitapalli, R., Jagannath, S., & Dhodapkar, M. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052136 · Cited by 135
Neri, P. E., Kumar, S. K., Fulciniti, M. T., Vallet, S., Chhetri, S., Mukherjee, S., Tai, Y., Chauhan, D., Tassone, P., Venuta, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0753 · Cited by 126
Self-citationEx vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Hayashi, T., Hideshima, T., Akiyama, M., Raje, N. S., Richardson, P. G. G., Chauhan, D., & Anderson, K. C. (2003) · Blood · doi:10.1182/blood-2002-09-2828 · Cited by 123
Self-citationTargeted therapy of multiple myeloma based upon tumor-microenvironmental interactions
Anderson, K. C. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.01.024 · Cited by 120
Self-citationA clinically relevant SCID-hu in vivo model of human multiple myeloma
Tassone, P., Neri, P. E., Carrasco, D. R., Burger, R., Goldmacher, V. S., Fram, R. J., Munshi, V. N., Shammas, M. A., Catley, L. P., Jacob, G. S., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0373 · Cited by 115
Self-citationImpaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma
Brimnes, M. K., Svane, I. M., & Johnsen, H. E. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03037.x · Cited by 111
Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9
Vollmer, J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.673 · Cited by 56
Kukreja, A., Hutchinson, A., Mazumder, A., Vesole, D. H., Angitapalli, R., Jagannath, S., O’Connor, O. A., & Dhodapkar, M. V. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06369.x · Cited by 36
Novel targets for myeloma bone disease
Roodman, G. D. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1377 · Cited by 35
Krieg, A. Μ. (2007) · Nature Immunology · doi:10.1038/ni0507-475 · Cited by 24
Synopsis of a Roundtable on Validating Novel Therapeutics for Multiple Myeloma
Dalton, W. S., & Anderson, K. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1489 · Cited by 18
Self-citation
Cited by
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790
Tai, Y.-T., Mayes, P. A., Acharya, C., Zhong, M. Y., Cea, M., Cagnetta, A., Craigen, J., Yates, J., Gliddon, L., Fieles, W., et al. (2014) · Blood · doi:10.1182/blood-2013-10-535088 · Cited by 484
Self-citationTargeting the bone marrow microenvironment in multiple myeloma
Kawano, Y., Moschetta, M., Manier, S., Glavey, S., Görgün, G. T., Roccaro, A. M., Anderson, K. C., & Ghobrial, I. M. (2015) · Immunological Reviews · doi:10.1111/imr.12233 · Cited by 391
Self-citationTai, Y.-T., Acharya, C., An, G., Moschetta, M., Zhong, M. Y., Feng, X., Cea, M., Cagnetta, A., Wen, K., van Eenennaam, H., et al. (2016) · Blood · doi:10.1182/blood-2016-01-691162 · Cited by 350
Self-citationSisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S., Poyet, G., Labidi-Galy, S. I., Goddard-Leon, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3468 · Cited by 345
Metadata
- Authors
- Chauhan, D., Singh, A. V., Brahmandam, M., Carrasco, R., Bandi, M., Hideshima, T., Bianchi, G., Podar, K., Tai, Y.-T., Mitsiades, C., Raje, N., Jaye, D. L., Kumar, S. K., Richardson, P., Munshi, N., & Anderson, K. C.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 16
- Issue
- 4
- Pages
- 309-323
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2053706526
- Cited by
- 286
- References
- 50
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.